You are not logged in.
Pages: 1
Value is best assessed through consistency, verifiable purity, and regulatory compliance—not cost alone.
As mentioned previously, short-onset compounds have a greater abuse liability; further, compounds that have fewer adverse effects while they are active are likely to be preferred.
Pages: 1